Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T18:32:59.853Z.
Consensus retrieved: 2026-10-06T16:32:08.948Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T18:32:59.853Z.
Quote observation: 2026-10-06T18:29:46.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 108f8fd7c16ea3ee173cf4c928fb1762d5fda8f0ed14c05de6879cdcb1b92349
Forward PE Ratio (N/A) = Dated Quote Price ($1.21) / Consensus Forward EPS ($-0.56)
FORWARD PE RATIO
N/A
Sonoma Pharmaceuticals, Inc.
Market Cap
$5.79M
Forward PE Ratio
N/A
Market Cap
$5.58M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | $5.79M | N/A |
| Lucyd, Inc (LUCY)vs › | $5.86M | N/A |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $5.89M | N/A |
| enVVeno Medical Corporation (NVNO)vs › | $5.70M | N/A |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.89M | N/A |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.59M | N/A |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.58M | N/A |
| Scienture Holdings, Inc. (SCNX)vs › | $6.08M | N/A |
| Soligenix, Inc. (SNGX)vs › | $5.34M | N/A |
| Biomerica, Inc. (BMRA)vs › | $6.27M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2027-03-31
At the dated quote price of $1.21, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2027-03-31 | $-0.56 | $-0.56 – $-0.56 | 1 | n/m |
| 2028-03-31 | $0.07 | $0.07 – $0.07 | 1 | 17.3x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
